Providers can score MIPS credit by reporting COVID-19 clinical data

The CMS on Monday encouraged providers to share clinical data in the Quality Payment Program that could help combat the COVID-19 pandemic.

The agency will give providers credit in the Merit-Based Incentive Payment System if they participate in a clinical trial that uses a drug or biologic to treat COVID-19 and report the data to the CMS. The hope is the increased participation will help improve patient care and find best practices that could curb the virus’ spread.

“The best scientific and medical minds in the world are working night and day to find treatments to combat coronavirus,” CMS Administrator Seema Verma said in a statement. “But without solid data, their efforts are liable to run up against a brick wall.”

Full Article